FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Pfizer Zarontin Recall

Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Nether…

Pfizer Inc. · New York, NY

Risk level
Class III
Reported by FDA
Oct 2, 2019
Recall ID
D-0002-2020
Check your lot numberHow we source this data

Summary

Pfizer recalled Zarontin starting Sep 12, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0002-2020 on Oct 2, 2019. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.

Product description

Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24

Lot numbers, UPCs & expiration codes

Lot #3267079, Exp 09/2021

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0002-2020
Classification
Class III
Status
Terminated
Recall initiated
Sep 12, 2019
FDA report date
Oct 2, 2019
Quantity
7,686 100-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-0002-2020, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
83788
Address
235 E 42nd St
Code information
Lot #3267079, Exp 09/2021
Postal code
10017-5703
Report date
Oct 2, 2019
Product type
Drugs
Recall number
D-0002-2020
Classification
Class III
Recalling firm
Pfizer Inc.
Product quantity
7,686 100-count bottles
Termination date
Apr 10, 2023
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24
Distribution pattern
Nationwide in the USA
Recall initiation date
Sep 12, 2019
Initial firm notification
Letter
Center classification date
Oct 1, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0002-2020, published Oct 2, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls